DE2242563A1 - Anordnung zur analyse biologischer zellen - Google Patents
Anordnung zur analyse biologischer zellenInfo
- Publication number
- DE2242563A1 DE2242563A1 DE19722242563 DE2242563A DE2242563A1 DE 2242563 A1 DE2242563 A1 DE 2242563A1 DE 19722242563 DE19722242563 DE 19722242563 DE 2242563 A DE2242563 A DE 2242563A DE 2242563 A1 DE2242563 A1 DE 2242563A1
- Authority
- DE
- Germany
- Prior art keywords
- cell
- signal
- cells
- arrangement according
- pulse
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004458 analytical method Methods 0.000 title claims description 9
- 210000004027 cell Anatomy 0.000 claims description 944
- 238000012545 processing Methods 0.000 claims description 153
- 230000002159 abnormal effect Effects 0.000 claims description 74
- 210000004940 nucleus Anatomy 0.000 claims description 68
- 239000010453 quartz Substances 0.000 claims description 61
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 61
- 239000000463 material Substances 0.000 claims description 32
- 238000005070 sampling Methods 0.000 claims description 25
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 20
- 238000004088 simulation Methods 0.000 claims description 18
- 230000001413 cellular effect Effects 0.000 claims description 12
- 230000008859 change Effects 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 210000003855 cell nucleus Anatomy 0.000 claims description 10
- 238000010894 electron beam technology Methods 0.000 claims description 10
- 230000031700 light absorption Effects 0.000 claims description 9
- 238000003860 storage Methods 0.000 claims description 9
- 230000000903 blocking effect Effects 0.000 claims description 8
- 210000005265 lung cell Anatomy 0.000 claims description 7
- 230000033001 locomotion Effects 0.000 claims description 4
- 229910052698 phosphorus Inorganic materials 0.000 claims description 4
- 239000011574 phosphorus Substances 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 230000005855 radiation Effects 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 3
- 238000011156 evaluation Methods 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 230000005540 biological transmission Effects 0.000 claims 1
- 230000009087 cell motility Effects 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 230000001678 irradiating effect Effects 0.000 claims 1
- 239000003973 paint Substances 0.000 claims 1
- 239000004020 conductor Substances 0.000 description 342
- 239000011162 core material Substances 0.000 description 94
- 238000012360 testing method Methods 0.000 description 73
- 239000000523 sample Substances 0.000 description 71
- 210000002435 tendon Anatomy 0.000 description 46
- 230000000875 corresponding effect Effects 0.000 description 43
- 210000000805 cytoplasm Anatomy 0.000 description 27
- 239000000243 solution Substances 0.000 description 17
- 239000012634 fragment Substances 0.000 description 14
- 230000001960 triggered effect Effects 0.000 description 14
- 239000002131 composite material Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 238000010521 absorption reaction Methods 0.000 description 10
- 239000002245 particle Substances 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 8
- 230000002829 reductive effect Effects 0.000 description 8
- 230000006870 function Effects 0.000 description 7
- 230000003287 optical effect Effects 0.000 description 7
- 230000002441 reversible effect Effects 0.000 description 6
- 230000007704 transition Effects 0.000 description 6
- 239000002699 waste material Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 230000005284 excitation Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000000007 visual effect Effects 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 230000001788 irregular Effects 0.000 description 3
- 230000036961 partial effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000032900 absorption of visible light Effects 0.000 description 2
- 230000002238 attenuated effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 210000003850 cellular structure Anatomy 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000009795 derivation Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 210000003701 histiocyte Anatomy 0.000 description 2
- 239000007970 homogeneous dispersion Substances 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 230000007257 malfunction Effects 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 230000001360 synchronised effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- QPFMBZIOSGYJDE-UHFFFAOYSA-N 1,1,2,2-tetrachloroethane Chemical compound ClC(Cl)C(Cl)Cl QPFMBZIOSGYJDE-UHFFFAOYSA-N 0.000 description 1
- 241001136792 Alle Species 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical class [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000000592 Artificial Cell Substances 0.000 description 1
- -1 Beryllium silicates Chemical class 0.000 description 1
- 229920013660 Cellon Polymers 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 208000036829 Device dislocation Diseases 0.000 description 1
- 206010027146 Melanoderma Diseases 0.000 description 1
- 241000656145 Thyrsites atun Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000012550 audit Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 229910052790 beryllium Inorganic materials 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- QZVSYHUREAVHQG-UHFFFAOYSA-N diberyllium;silicate Chemical compound [Be+2].[Be+2].[O-][Si]([O-])([O-])[O-] QZVSYHUREAVHQG-UHFFFAOYSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 description 1
- 239000011824 nuclear material Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000012958 reprocessing Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000679 solder Inorganic materials 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000026676 system process Effects 0.000 description 1
- 238000013024 troubleshooting Methods 0.000 description 1
- 238000004148 unit process Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1468—Optical investigation techniques, e.g. flow cytometry with spatial resolution of the texture or inner structure of the particle
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Dispersion Chemistry (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Image Processing (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19722242563 DE2242563A1 (de) | 1972-08-30 | 1972-08-30 | Anordnung zur analyse biologischer zellen |
| FR7231583A FR2198632A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1972-08-30 | 1972-09-06 | |
| CH1455472A CH585904A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1972-08-30 | 1972-10-03 | |
| GB4713472A GB1407838A (en) | 1972-08-30 | 1972-10-12 | Biological cell scanning system |
| CA153,963A CA991438A (en) | 1972-08-30 | 1972-10-16 | Biological cell analyzing system |
| CA250,384A CA1036385A (en) | 1972-08-30 | 1976-04-15 | Biological cell analyzing system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19722242563 DE2242563A1 (de) | 1972-08-30 | 1972-08-30 | Anordnung zur analyse biologischer zellen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2242563A1 true DE2242563A1 (de) | 1974-03-21 |
Family
ID=5854955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19722242563 Pending DE2242563A1 (de) | 1972-08-30 | 1972-08-30 | Anordnung zur analyse biologischer zellen |
Country Status (5)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4665553A (en) * | 1984-05-01 | 1987-05-12 | Ortho Diagnostics Systems Inc. | Methods and apparatus for analysis of particles and cells |
| WO1994010564A1 (de) * | 1992-11-05 | 1994-05-11 | Evotec Biosystems Gmbh | Verfahren zur trennung von substanzen aus verdünnten lösungen oder suspensionen |
| US5733739A (en) * | 1995-06-07 | 1998-03-31 | Inphocyte, Inc. | System and method for diagnosis of disease by infrared analysis of human tissues and cells |
| US5733507A (en) * | 1995-06-07 | 1998-03-31 | Inphocyte, Inc. | Biological cell sample holder for use in infrared and/or Raman spectroscopy analysis holder |
| US5848977A (en) * | 1996-02-16 | 1998-12-15 | Inphocyte, Inc. | Sample holder for cells |
| US20150269314A1 (en) | 2014-03-20 | 2015-09-24 | Rudjer Boskovic Institute | Method and apparatus for unsupervised segmentation of microscopic color image of unstained specimen and digital staining of segmented histological structures |
| CN113640195B (zh) * | 2021-02-03 | 2022-10-11 | 深圳市帝迈生物技术有限公司 | 试剂盒、poct血细胞分析仪 |
-
1972
- 1972-08-30 DE DE19722242563 patent/DE2242563A1/de active Pending
- 1972-09-06 FR FR7231583A patent/FR2198632A5/fr not_active Expired
- 1972-10-03 CH CH1455472A patent/CH585904A5/xx not_active IP Right Cessation
- 1972-10-12 GB GB4713472A patent/GB1407838A/en not_active Expired
- 1972-10-16 CA CA153,963A patent/CA991438A/en not_active Expired
-
1976
- 1976-04-15 CA CA250,384A patent/CA1036385A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR2198632A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1974-03-29 |
| CA1036385A (en) | 1978-08-15 |
| GB1407838A (en) | 1975-09-24 |
| CH585904A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1977-03-15 |
| CA991438A (en) | 1976-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3146423C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| DE3719923C2 (de) | Bilderzeugungsvorrichtung, insbesondere für Materialien mit geringer Ordnungszahl | |
| DE69921463T2 (de) | Verfahren um blutzellzählungen durchzuführen | |
| DE3039825A1 (de) | Verfahren und einrichtung zur bestimmung der bewegungsfaehigkeit von spermazellen | |
| EP1248947B1 (de) | Verfahren und vorrichtung zur charakterisierung einer kulturflüssigkeit | |
| DE69031682T2 (de) | Thionin Färbungstechnik | |
| DE1498824A1 (de) | Vorrichtung zur maschinellen Krebsdiagnose | |
| DE2929170A1 (de) | Verfahren und vorrichtung zur erzeugung des fluoreszenz-emissionsspektrums von partikeln | |
| DE2543124A1 (de) | Verfahren zur unterscheidung zwischen diskreten teilchen sowie vorrichtung zur durchfuehrung des verfahrens | |
| DE2422016A1 (de) | Diagnose von krankheitszustaenden durch fluoreszenzmessungen unter verwendung von abtastlaserstrahlen | |
| DE19826062A1 (de) | Verfahren und Anordnung zur Detektion von Röntgenstrahlen | |
| DE2551026C3 (de) | Verfahren zur Analysieren von Teilchen | |
| DE102019121446A1 (de) | Quantitatives Charakterisierungsverfahren für die Fläche und für den Inhalt unterschiedlicher Typen von Einschlüssen in Stahl | |
| DE4023156C2 (de) | Verfahren zum Untersuchen eines auf der geneigten Bodenfläche eines Reaktionsgefäßes entstandenen Partikelmusters | |
| DE2820254A1 (de) | Verfahren und vorrichtung zur analyse der partikelgroesse | |
| DE69117692T2 (de) | Gerät und Verfahren zum Verarbeiten von Röntgenbilddaten | |
| DE2242563A1 (de) | Anordnung zur analyse biologischer zellen | |
| EP3430565B1 (de) | Verfahren zur untersuchung verteilter objekte unter segmentierung eines übersichtbildes | |
| DE10013012A1 (de) | Röntgenfluoreszenzanalysevorrichtung | |
| DE2450112C3 (de) | Verfahren und Anordnung zur zerstörungsfreien Analyse biologischer Zeilen einer mindestens zwei unterschiedliche, licht bekannter Wellenlänge unterschiedlich stark absorbierende Zellentypen in zueinander festgelegter Lage enthaltenden Probe | |
| DE2004707A1 (de) | Chromatografische Platte | |
| EP3040705A1 (de) | Verfahren zum Bestimmen von Partikeln | |
| DE1800993A1 (de) | Verfahren zur automatisierten elektronischen densitometrischen Auswertung von mit Hilfe der sogenannten traegerfreien Elektrophorese getrennten Stoffgemischen | |
| DE3636506A1 (de) | Spiralabtastverfahren | |
| EP1154370B1 (de) | Automatische Bonitierung von biologischen Objekten auf der Basis dynamischer Farbanalyse mit nachfolgender Grössen- und Formanalyse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OHA | Expiration of time for request for examination |